Pharmacovigilance Market is expected to cross USD 10,881.03 Million by 2025 at a CAGR of 14.1%. - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Pharmacovigilance Market is expected to cross USD 10,881.03 Million by 2025 at a CAGR of 14.1%.

Description:

According to MRFR analysis, Pharmacovigilance Market is expected to register a CAGR of 14.1% during the forecast period of 2019 to 2025 and accounts for USD 4321.86 Million 2018. – PowerPoint PPT presentation

Number of Views:2
Date added: 27 January 2020
Slides: 7
Provided by: sagar000777

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Pharmacovigilance Market is expected to cross USD 10,881.03 Million by 2025 at a CAGR of 14.1%.


1
Pharmacovigilance Market is expected to cross
USD 10,881.03 Million by 2025 at a CAGR of 14.1.
SAMPLE
FOR MORE INFO
2
Pharmacovigilance Market
Market Highlights According to MRFR analysis,
Pharmacovigilance Market is expected to register
a CAGR of 14.1 during the forecast period of
2019 to 2025 and accounts for USD 4321.86 Million
2018. Pharmacovigilance supports safe and
appropriate use of drugs by identifying risk
factors for the development of adverse drug
reactions (ADR), promoting the detection of
previously unknown ADR and their interactions
with known ADR. The market is dominated by
numerous established players. The key players are
involved in product launches and strategic
collaborations to strengthen their market
positions. For instance, on May 16, 2019,
Accenture launched INTENT to improve the
continuity and flow of data across life sciences
enterprises, supporting the delivery of
ground-breaking treatments for patients.
Request For Free Sample Report
https//www.marketresearchfuture.com/sample_reques
t/8451
3
Pharmacovigilance Market
Segmentation The Global Pharmacovigilance Market
has been segmented based on the clinical trial
phase, service provider, type, and end-user. The
market, based on the clinical trial phase, has
been divided into phase IV, phase III, phase II,
phase I, and pre-clinical. Phase IV segment
dominated the pharmacovigilance market as adverse
drug reactions are majorly detected in this
phase. Whereas, phase III is expected to witness
the fastest growth. The global pharmacovigilance
market has been segmented, on the basis of
service provider, into in-house and contract
outsourcing. Contract outsourcing dominated the
global pharmacovigilance market and expected to
witness the fastest growth. Contract
manufacturing serves multiple customers and thus
can acquire raw materials at a reduced cost,
benefiting from the economies of scale. The
market, based on type, has been divided into
spontaneous reporting, cohort event monitoring,
intensified ADR reporting, targeted spontaneous
reporting, and EHR mining. The spontaneous
reporting held largest market share in 2018.
Spontaneous reporting is a passive approach to
pharmacovigilance as it entirely relies on the
motivation of individuals to report suspected
ADRs to a local or national pharmacovigilance
center. Browse Full Report Details _at_
https//www.marketresearchfuture.com/reports/pharm
acovigilance-market-8451
4
Pharmacovigilance Market
Regional Analysis The market has been divided, by
region, into the Americas, Europe, Asia-Pacific,
and the Middle East Africa. The Americas is
expected to be the largest market owing to the
high spending by the pharmaceutical industry. The
pharmacovigilance market in the Americas has
further been branched into North America and
Latin America, with the North American market
divided into the US and Canada. The European
Pharmacovigilance market has been categorized as
Western Europe and Eastern Europe. The Western
European market has further been classified as
Germany, France, the UK, Italy, Spain, and the
rest of Western Europe. The Pharmacovigilance
market in Asia-Pacific has been segmented into
Japan, China, India, South Korea, Australia, and
the rest of Asia-Pacific. Due to the increasing
prevalence of chronic conditions and rising cases
of ADRs and medication errors, the market in
Asia-Pacific is expected to be the
fastest-growing. The pharmacovigilance market in
the Middle East Africa has been divided into
the Middle East and Africa. Key Players Some of
the key players in the Global Pharmacovigilance
Market are Accenture (Ireland), ArisGlobal (US),
BioClinica (US), Capgemini (France), Conquest
Group BV (Netherlands), Cognizant (US), IBM
Corporation (US), ICON PLC (Ireland), IMEDGlobal
(US), ITClinical (Portugal), Laboratory
Corporation of America Holdings (US), PAREXEL
International Corporation (US), TAKE Solutions
Ltd (India), United BioSource Corporation (US),
and Wipro Ltd (India).
5
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
6
(No Transcript)
About PowerShow.com